<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03942146</url>
  </required_header>
  <id_info>
    <org_study_id>Q4-15-035 E4</org_study_id>
    <nct_id>NCT03942146</nct_id>
  </id_info>
  <brief_title>Smoking Cessation Prior to Gynecological Surgery</brief_title>
  <official_title>Smoking Cessation Prior to Gynecological Surgery - a Registry-based Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Swedish National Quality Registries</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Swedish Research Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Swedish National Register for gynecological surgery</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sahlgrenska University Hospital, Sweden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates whether current smokers scheduled for gynecological surgery will stop
      smoking to a higher extent if they or the surgeon is exposed to information on smoking
      cessation prior to surgery in a web-based questionnaire in the Swedish National quality
      register for gynecological surgery, GynOp.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Peri-operative smoking cessation should be introduced 4-6 weeks before surgery and continued
      4-6 weeks after surgery to decrease postoperative complications. The purpose of the study is
      to increase the exposure to smoking cessation information pior to surgery using a web-based
      quality register. The hypothesis is that this will lead to an increase in perioperative
      smoking cessation.

      Women scheduled for gynecological surgery who report current smoking will be enrolled in the
      study. They will be randomly assigned to different sources of information about smoking
      cessation before surgery. The web-based Swedish national quality register for gynecological
      surgery, GynOp, will be utilized for randomization, obtaining information about the
      participant and the surgery performed as well as for follow-up.

      GynOp The register was established in 1997 and 90% of gynecological surgical clinics in
      Sweden contribute information. The conversion from paper forms to on-line registration
      started in 2008. When scheduled for surgery a health declaration and a questionnaire about
      symptoms is sent to the patients primarily via their e-mail address for direct on-line
      registration. This is used in 41% of the cases and the response rate has been reported to be
      83%. If an e-mail address is missing, or if preferred by the patient, information is obtained
      by postal questionnaires (today used in 59% with a response rate of 87%). It has been
      previously reported that there were no differences in patient characteristics between these
      two means of contact except that patients without an e-mail address were slightly older and
      answered more frequently than patients with e-mail. The advantage of the web-based version is
      not only that the health declaration is sent directly to the clinic and automatically
      included in the medical record, but relevant information to the patient can be added in the
      health declaration. The on-line web-version can also be used in a randomization process,
      which we will utilize in this study.

      Data in the register is collected prospectively from patient questionnaires and doctors'
      forms. The patient receives written information about the register and has the opportunity to
      decline participation. Pre-operatively, the patient fills in a questionnaire including a
      health declaration with questions on comorbidity, medication and smoking status. The surgeon
      registers data on preoperative findings and surgical history at the enrollment before
      surgery. Peroperative data and events before discharge are also registered in two different
      forms by the surgeon. Eight weeks postoperatively the patient receives a questionnaire with
      questions concerning the results of the surgery and any complaints or complications. The
      forms are evaluated by the surgeon and data registered if there have been any complications.

      The randomisation process

      When smoking is reported by the participant in the web-based health declaration, she is
      automatically randomized to one of four alternatives. The allocation ratio of randomization
      will be 1:4 between the 4 arms:

      Group 1 serves as a control group and receives no specific information about smoking
      cessation Group 2 the participant receives directly the following written recommendation in
      the web-based health declaration &quot;You have increased risks due to smoking. Smoking cessation
      6 weeks before surgery and 6 weeks after surgery is recommended&quot; Group 3 The smoking status
      of the patient is alerted to the surgeon when filling in the preoperative form with the text
      &quot; the patient smokes, recommend smoking cessation&quot; Group 4, is a combination of Group 2 and
      3, i.e. a written recommendation is included in the web-based health declaration as in group
      2 and in addition the surgeon is alerted that the patient is a smoker and instructed to
      recommend smoking cessation as in group 3.

      In the postoperative questionnaire two months after surgery the participant is asked to
      participate in a research study including questions about smoking cessation and an informed
      consent form will be presented and completed. Hence, she will thereby be blinded to the study
      when she receives the smoking cessation information in the preoperative questionnaire. The
      intention for this procedure is to avoid introducing any bias of being included in a study
      and to be able to study the effect of a recommendation in the register in a real world
      setting. This was accepted by the Ethics Committee and to be exposed to smoking cessation
      information was not considered an ethical problem as patients are routinely given written
      information on smoking cessation by the clinics even outside the study. The patient has the
      opportunity to decline participation two months after surgery when the additional
      questionnaire on smoking cessation is presented.

      Five questions on smoking cessation will be added to the ordinary postoperative
      questionnaire. The questions includes whether or not the woman has received smoking cessation
      information, from whom she has been given the information and the duration of smoking
      cessation in connection to surgery. These questions has gone through several phases of
      validation prior to study start. The randomization process in the register has also been
      tested thoroughly since this is the first time a randomized study is carried out in this
      register.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 5, 2015</start_date>
  <completion_date type="Actual">December 6, 2017</completion_date>
  <primary_completion_date type="Actual">December 6, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>When smoking is reported by the participant in the web-based health declaration, she is automatically randomized to one of four alternatives. The allocation ratio of randomization is 1:4 between the 4 arms: Group 1 serves as a control group and receives no specific information about smoking cessation; In Group 2 the patient receives directly the following written recommendation in the web-based health declaration &quot;You have increased risks due to smoking. Smoking cessation 6 weeks before surgery and 6 weeks after surgery is recommended&quot;; Group 3 The smoking status of the participant is alerted to the surgeon when filling in the preoperative form with the text &quot; the patient smokes, recommend smoking cessation&quot;; and Group 4, is a combination of Group 2 and 3, i.e. a written recommendation is included in the web-based health declaration as in group 2 and in addition the surgeon is alerted that the patient is a smoker and instructed to recommend smoking cessation as in group 3.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>Care provider will not be informed about the study Participant is not informed about the study until the follow-up questionnaire 2 months after surgery</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Smoking cessation</measure>
    <time_frame>At two months after surgery</time_frame>
    <description>Change in smoking habits measured by a questionnaire two months after surgery. The participants were asked to report their smoking habits at 6 weeks, 3-6 weeks and 1-3 weeks before surgery, the week of surgery and 1-3 weeks and 3-6 weeks after surgery. The answering alternatives were &quot;did not smoke&quot;, &quot;smoked less than ususal&quot; or &quot;smoked as usual&quot;. The rate of nonsmoking will be measured at the different time span before and after surgery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative complications</measure>
    <time_frame>Registered complications within 8 weeks after surgery</time_frame>
    <description>The rate of minor and major complications, including infections after surgery</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">1609</enrollment>
  <condition>Smoking Cessation</condition>
  <condition>Surgery--Complications</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No information on smoking cessation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Written information, GynOp</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>When reporting being a current smoker in the health declaration on-line the participant receives the following written recommendation in the web-based health declaration &quot;You have increased risks due to smoking. Smoking cessation 6 weeks before surgery and 6 weeks after surgery is recommended&quot;</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Doctor informed</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The smoking status of the participant is alerted to the surgeon when filling in the preoperative form with the text &quot; the patient smokes, recommend smoking cessation&quot;</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Written information, GynOp + doctor informed</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A combination of Group 2 and 3, i.e. a written recommendation is included in the web-based health declaration as in group 2 and in addition the surgeon is alerted that the participant is a smoker and instructed to recommend smoking cessation as in group 3.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Information on smoking cessation</intervention_name>
    <description>Smoking cessation is recommended 6 weeks before and after surgery</description>
    <arm_group_label>Doctor informed</arm_group_label>
    <arm_group_label>Written information, GynOp</arm_group_label>
    <arm_group_label>Written information, GynOp + doctor informed</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Planned gynecological surgery and invited to participate in GynOp

          -  Current smokers

          -  Ability to fill in a web-version of a questionnaire in Swedish

        Exclusion Criteria:

          -  Non-smokers

          -  Surgery was not performed

          -  No response to follow-up questionnaire
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>A person who is about to undergo gynecological surgery due to a gynecological disorder</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Katja S Bohlin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Obstetrics and Gynecology Sahlgrenska University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Obstetrics and gynecology</name>
      <address>
        <city>Gothenburg</city>
        <zip>41345</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 5, 2019</study_first_submitted>
  <study_first_submitted_qc>May 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 8, 2019</study_first_posted>
  <last_update_submitted>May 8, 2019</last_update_submitted>
  <last_update_submitted_qc>May 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sahlgrenska University Hospital, Sweden</investigator_affiliation>
    <investigator_full_name>Katja Stenstr√∂m Bohlin</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Randomised registry-based trial</keyword>
  <keyword>smoking cessation</keyword>
  <keyword>surgery</keyword>
  <keyword>complications</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The study is completed and data will be described in a scientific publication within six months</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

